Cargando…

When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy

Recent significant strides of natural compounds in immunomodulation have highlighted their great potential against cancer. Despite many attempts being made for cancer immunotherapy, the biomedical application of natural compounds encounters a bottleneck because of their unclear mechanisms, low solub...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Linna, Jin, Yi, Song, Mingjie, Zhao, Yu, Zhang, Huaqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412684/
https://www.ncbi.nlm.nih.gov/pubmed/36015215
http://dx.doi.org/10.3390/pharmaceutics14081589
_version_ 1784775554815229952
author Yu, Linna
Jin, Yi
Song, Mingjie
Zhao, Yu
Zhang, Huaqing
author_facet Yu, Linna
Jin, Yi
Song, Mingjie
Zhao, Yu
Zhang, Huaqing
author_sort Yu, Linna
collection PubMed
description Recent significant strides of natural compounds in immunomodulation have highlighted their great potential against cancer. Despite many attempts being made for cancer immunotherapy, the biomedical application of natural compounds encounters a bottleneck because of their unclear mechanisms, low solubility and bioavailability, and limited efficacy. Herein, we summarize the immune regulatory mechanisms of different natural compounds at each step of the cancer-immunity cycle and highlight their anti-tumor potential and current limitations. We then propose and present various drug delivery strategies based on nanotechnology, including traditional nanoparticles (NPs)-based delivery strategies (lipid-based NPs, micelles, and polysaccharide/peptide/protein-based NPs) and novel delivery strategies (cell-derived NPs and carrier-free NPs), thus providing solutions to break through existing bottlenecks. Furthermore, representative applications of nature-inspired nanomedicines are also emphasized in detail with the advantages and disadvantages discussed. Finally, the challenges and prospects of natural compounds for cancer immunotherapy are provided, hopefully, to facilitate their far-reaching development toward clinical translation.
format Online
Article
Text
id pubmed-9412684
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94126842022-08-27 When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy Yu, Linna Jin, Yi Song, Mingjie Zhao, Yu Zhang, Huaqing Pharmaceutics Review Recent significant strides of natural compounds in immunomodulation have highlighted their great potential against cancer. Despite many attempts being made for cancer immunotherapy, the biomedical application of natural compounds encounters a bottleneck because of their unclear mechanisms, low solubility and bioavailability, and limited efficacy. Herein, we summarize the immune regulatory mechanisms of different natural compounds at each step of the cancer-immunity cycle and highlight their anti-tumor potential and current limitations. We then propose and present various drug delivery strategies based on nanotechnology, including traditional nanoparticles (NPs)-based delivery strategies (lipid-based NPs, micelles, and polysaccharide/peptide/protein-based NPs) and novel delivery strategies (cell-derived NPs and carrier-free NPs), thus providing solutions to break through existing bottlenecks. Furthermore, representative applications of nature-inspired nanomedicines are also emphasized in detail with the advantages and disadvantages discussed. Finally, the challenges and prospects of natural compounds for cancer immunotherapy are provided, hopefully, to facilitate their far-reaching development toward clinical translation. MDPI 2022-07-30 /pmc/articles/PMC9412684/ /pubmed/36015215 http://dx.doi.org/10.3390/pharmaceutics14081589 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Yu, Linna
Jin, Yi
Song, Mingjie
Zhao, Yu
Zhang, Huaqing
When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy
title When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy
title_full When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy
title_fullStr When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy
title_full_unstemmed When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy
title_short When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy
title_sort when natural compounds meet nanotechnology: nature-inspired nanomedicines for cancer immunotherapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412684/
https://www.ncbi.nlm.nih.gov/pubmed/36015215
http://dx.doi.org/10.3390/pharmaceutics14081589
work_keys_str_mv AT yulinna whennaturalcompoundsmeetnanotechnologynatureinspirednanomedicinesforcancerimmunotherapy
AT jinyi whennaturalcompoundsmeetnanotechnologynatureinspirednanomedicinesforcancerimmunotherapy
AT songmingjie whennaturalcompoundsmeetnanotechnologynatureinspirednanomedicinesforcancerimmunotherapy
AT zhaoyu whennaturalcompoundsmeetnanotechnologynatureinspirednanomedicinesforcancerimmunotherapy
AT zhanghuaqing whennaturalcompoundsmeetnanotechnologynatureinspirednanomedicinesforcancerimmunotherapy